Kerr Holbrook - Mar 4, 2025 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP, Chief Commercial Officer
Signature
/s/ Mojirade James, as attorney-in-fact for Kerr W. Holbrook
Stock symbol
AVNS
Transactions as of
Mar 4, 2025
Transactions value $
-$50,625
Form type
4
Date filed
3/6/2025, 02:24 PM
Previous filing
Mar 19, 2024
Next filing
Mar 10, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Options Exercise $0 +5.15K +5.9% $0.00 92.4K Mar 4, 2025 Direct F1, F2
transaction AVNS Common Stock Tax liability -$27.3K -1.8K -1.95% $15.13 90.6K Mar 4, 2025 Direct F3
transaction AVNS Common Stock Tax liability -$23.3K -1.54K -1.7% $15.13 89K Mar 4, 2025 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents performance-based restricted share units (PRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each PRSU is the economic eqiuvalent of one share of Common Stock.
F2 Total beneficially owned includes 117 shares acquired on December 31, 2024 and 1,000 shares acquired on June 30, 2024 under the Issuer's Employee Stock Purchase Plan.
F3 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 5,145 PRSUs which vested on March 4, 2025.
F4 Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 4,403 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 4, 2022 and (ii) vested on March 4, 2025. Each TRSU is the economic equivalent of one share of Common Stock.